Mirtazapine-Induced Thrombocytopenia and Neutropenia
Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 3
Abstract
To the Editor, Neutropenia is a rare and commonly reversible sideeffect of antidepressant treatment [1]. Mirtazapine is a noradrenergic and specific serotonergic antidepressant that is approved for use in the treatment of major depression in many countries [2]. A major hematological side effect of mirtazapine is agranulocytosis. Herein we report a patient with depression that developed severe neutropenia-associated thrombocytopenia during treatment with mirtazapine; the patient was safely treated by switching to another drug.
Authors and Affiliations
Selami Toprak, Elçin Erdogan, Özlem Azap
Keywords
Related Articles
- EP ID EP116634
- DOI 10.5505/tjh.2012.72325
- Views 74
- Downloads 0
Rituximab-Related Reversible Hepatocellular Damage
To the Editor, Since its approval in 1997 by the US Food and Drug Administration, use of rituximab (MabThera®, Roche,Switzerland) has become widespread, especially for the treatment of non-Hodgkin lymphoma (NHL) and chr...
Diagnosis: Melanoderma after Hematopoietic Stem Cell Transplantation
Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?
Objective: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred...
Akut Lenfoblastik Lösemi Tanısı Olan İleri Yaş Hastada Meme Kanserini Taklit Eden İzole Meme Nüksü
A Pediatric Patient with Intravenous Cyclosporine Anaphylaxis Who Tolerated the Oral Form